P.-D. Nguyen et al.
Phytochemistry 190 (2021) 112891
using an isocratic mode of 32% MeCN (pH = 2.4) to give 6 (28 mg, tR
=
982, 714 cmꢀ 1; CD [θ] nm (c 0.001, EtOH): +14,000 (223); +3000
(232), +9000 (241), ꢀ 2000 (280); 1H-NMR (CD3OD, 600 MHz) and 13C-
NMR (CD3OD, 125 MHz), see Table 2; HRESIMS m/z 761.1701
13.73 min), 8 (8.5 mg, tR = 21.60 min) and 12 (7 mg, tR = 27.19 min).
The HPLC chromatograms and the purification of known compounds
are described in the supplementary material section.
[M+Na]+ (calcd for C36H34O17Na, 761.1694).
25
Flacourtioside J (8): amorphous powder; [
α
]
ꢀ 17 (c 0.091,
MeOH); UV (MeOH) λ
(log
ε
) 280 (3.35) nm; IRD(KBr) νmax 3423,
3.4. Acid hydrolysis of the methanolic extract
max
2925, 1702, 1634, 1500, 1452, 1382, 1281, 1206, 1139, 1068, 715
cmꢀ 1; CD [θ] nm (c 0.001, EtOH): +21,000 (236), ꢀ 5000 (285), +5000
The MeOH extract (1 g) was refluxed in 2 N HCl (25 ml) for 4 h. After
extraction with EtOAc (3 × 25 ml), the aqueous layer was neutralized
with 0.5 M NaOH and freeze-dried. The sugar mixture was identified as
glucose by comparison with authentic sugar samples by TLC using
MeCOEt – i-PrOH – MeCOMe – H2O (20/10/7/6). Glucose was separated
(340); H-NMR (CD3OD, 600 MHz) and 13C-NMR (CD3OD, 125 MHz),
1
see Table 2; HRESIMS m/z 729.1791 [M+Na]+ (calcd for C36H34O15Na,
729.1795), 559.4258 [M-cinnamoyl]+.
25
Flacourtioside K (9): amorphous powder; [
α
]
D +17 (c 0.18, MeOH);
UV (MeOH) λmax (log ε) 272 (3.30) nm; CD [θ] nm (c 0.001, EtOH):
by semi-preparative HPLC (column 2) using an isocratic of H2SO4 2.5 μM
+18,000 (234); 1H-NMR (CD3OD, 600 MHz) and 13C-NMR (CD3OD, 125
MHz), see Table 2; HRESIMS m/z 583.1425 [M + Na]+ (calcd for
35%, then identified by chiral analytical HPLC (column 3) using an
isocratic of n-hexane/EtOH/TFA (80/20/1) in comparison with
authentic L-glucose and D-glucose.
C
27H28O13Na, 583.1428), 463.3469 [M + Na-benzoyl]+, 413.1277 [M
+ Na-cyclohexenoyl]+.
25
Flacourtioside L (10): amorphous powder; [α] D ꢀ 6 (c 0.11, MeOH);
3.5. Undescribed isolated compounds
UV (MeOH) λmax (log ε) 280 (3.36) nm; CD [θ] nm (c 0.001, EtOH):
+2000 (330); 1H-NMR (CD3OD, 600 MHz) and 13C-NMR (CD3OD, 125
MHz), see Table 3; HRESIMS m/z 583.1433 [M+Na]+ (calcd for
25
Compound (1): amorphous powder; [
α
]
+7 (c 0.35, MeOH); UV
(MeOH) λ
(log
ε
) 282 (3.4) nm; IR (KBrD) νmax 3413, 2928, 1701,
1601, 150m1a,x1455, 1379, 1276, 1209, 1074, 715 cmꢀ 1; CD [θ] nm (c
0.01, EtOH): +30,000 (224); +19,500 (241), +5000 (330); 1H-NMR
(CD3OD, 600 MHz) and 13C-NMR (CD3OD, 125 MHz) spectral data, see
Table 1; HRESMS m/z 599.1375 [M+Na]+ (calcd for C27H28O14Na
C
27H28O13Na, 583.1428), 429.1264 [M + Na-cyclohexenoyl]+.
Compound (11; 2′′-benzoyl-flacourtioside L): amorphous powder;
25
[
α]
D ꢀ 36 (c 0.24, MeOH); UV (MeOH) λmax (log
ε
) 282 (3.50) nm; CD
[θ] nm (c 0,001, EtOH): +4000 (220), ꢀ 26000 (231), +5000 (330); 1H-
NMR (CD3OD, 600 MHz) and 13C-NMR (CD3OD, 125 MHz), see Table 3;
HRESIMS m/z 687.1692 [M+Na]+ (calcd for C34H32O14Na, 687.1690),
599.1377), 473.1676 [M-benzoyl]+, 407.1434 [M-cyclohexenyl]+.
25
Compound (2): amorphous powder; [
α
]
D +39 (c 0.23, MeOH); UV
559.4116 [M-benzoyl]+.
(MeOH) λmax (log ε) 282 (3.6) nm; IR (KBr) νmax 3421, 2923, 1702,
25
1502, 1454, 1382, 1283, 1209, 1139, 1069, 964, 715 cmꢀ 1; CD [θ] nm (c
0.01, EtOH): +29,000 (235), +3000 (330); 1H-NMR (CD3OD, 600 MHz)
and 13C-NMR (CD3OD, 125 MHz) spectral data, see Table 1; HRESMS m/
z 599.1365 [M+Na]+ (calcd for C27H28O14Na 599.1377), 429.0976 [M-
Flacourtioside M (12): amorphous powder; [
α
]
ꢀ 20 (c 0.045,
D
MeOH); UV (MeOH) λ
(log ε) 328 (3.38), 294 (3.33) nm; IR (KBr)
max
νmax cmꢀ 1: 3422, 1682, 1602, 1499, 1453, 1385, 1273, 1206, 1139,
1074, 981, 714; 1H-NMR (CD3OD, 600 MHz) and 13C-NMR (CD3OD,
125 MHz), see Table 3; HRESIMS m/z 727.1626 [M+Na]+ (calcd for
benzoyl + Na]+.
C
36H32O15Na, 727.1639), 705.5147 [M+H]+.
25
Compound (3): amorphous powder; [
α
]
D +14 (c 0.25, MeOH); UV
25
Compound (13): amorphous powder; [
α]
+ 6.5 (c 0.79, MeOH);
D
(MeOH) λ
(log ε) 282 (3.7) nm; IR (KBr) νmax 3422, 2962, 1708,
1601, 150m1a,x1454, 1379, 1267, 1209, 1125, 1074, 987, 714 cmꢀ 1; CD
[θ] nm (c 0.01, EtOH): +31,000 (223); +11,500 (246), +3000 (330); 1H-
NMR (CD3OD, 600 MHz) and 13C-NMR (CD3OD, 125 MHz) spectral
data, see Table 1; HRESMS m/z 703.1647 [M+Na]+ (calcd for
UV (MeOH) λmax (log
ε
) 270 (3.19) nm; IR (KBr) νmax cmꢀ 1: 3424, 2938,
1681, 1599, 1514, 1463, 1417, 1331, 1234, 1204, 1128, 1078, 1038,
720, 658; 1H-NMR (CD3OD, 600 MHz) and 13C-NMR (CD3OD, 125
MHz), see Table 3; HRESIMS m/z 443.1537 [M+Na]+ (calcd for
34H32O15Na 703.1639), 533.1472 [M + Na-cyclohexenyl]+.
C
18H28O11Na, 443.1529), 389.1987 [M-OCH3]+, 241.1222 [M-
C
glucose]+.
25
Compound (4): amorphous powder; [
α
]
D ꢀ 16 (c 0.10, MeOH); UV
(MeOH) λ
(log ε) 282 (3.8) nm; IR (KBr) νmax 3423, 2922, 1708,
max
1601, 1502, 1453, 1380, 1281, 1209, 1067, 960, 713 cmꢀ 1; CD [θ] nm (c
0.01, EtOH): 1000 (220); ꢀ 10000 (230), +10,000 (245), +2000 (330);
1H-NMR (CD3OD, 600 MHz) and 13C-NMR (CD3OD, 125 MHz) spectral
data, see Table 1; HRESMS m/z 703.1630 [M+Na]+ (calcd for
Declaration of competing interest
The authors declare that they have no known competing financial
interests or personal relationships that could have appeared to influence
the work reported in this paper.
C
34H32O15Na 703.1639), 414.3108 [M-benzoyl-glucose]+.
25
Flacourtioside G (5): amorphous powder; [
α
]
D ꢀ 16 (c 0.22, MeOH);
Acknowledgments
UV (MeOH) λmax (log ε) 282 (3.40) nm; IR (KBr) νmax 3448, 2931, 1700,
1602, 1499, 1452, 1384, 1318, 1273, 1207, 1138, 1072, 1026, 712
cmꢀ 1; CD [θ] nm (c 0.001, EtOH): +15,000 (221), ꢀ 6000 (232),
+17,000 (241), ꢀ 1000 (280), +5000 (330); 1H-NMR (CD3OD, 600
MHz) and 13C-NMR (CD3OD, 125 MHz) spectral data, see Table 2;
HRESMS m/z 703.1645 [M+Na]+ (calcd for C34H32O15Na 703.1639),
The Ministry of Education in Vietnam (VIED) is acknowledged for
the 4-year doctoral fellowship for N.P.D. (grant 671/QD-BGDDT). D.
Harakat (ICMR) is thanked for measuring mass spectra, and A. Martinez
(ICMR) for molecular modeling and calculations. We are greatly
indebted to professor J. D. Connolly for fruitful discussions and careful
reading of the manuscript.
559.4249 [M-benzoyl]+, 397.2863 [M-benzoyl-glucose]+.
25
Flacourtioside H (6): amorphous powder; [
α
]
D ꢀ 29 (c 0.20, MeOH);
UV (MeOH) λmax (log ε) 328 (3.45), 294 (3.45) nm; IR (KBr) νmax 3421,
1706, 1603, 1501, 1452, 1379, 1273, 1178, 1117, 1071, 980, 712 cmꢀ 1
;
Appendix A. Supplementary data
CD [θ] nm (c 0.001, EtOH): +12,000 (220), ꢀ 5000 (232), +18,000
(241), ꢀ 1000 (280); 1H-NMR (CD3OD, 600 MHz) and 13C-NMR (CD3OD,
125 MHz) spectral data, see Table 2; HRESIMS m/z 865.1951 [M+Na]+
(calcd for C43H38O18Na, 865.1956), 703.1672 [M + Na-caffeoyl]+,
Supplementary data to this article can be found online at https://doi.
spectra of undescribed compounds (5–13).
413.2957 [M-glucose-benzoyl-caffeoyl]+.
25
Flacourtioside I (7): amorphous powder; [
α
]
D +15 (c 0.19, MeOH);
UV (MeOH) λmax (log
ε) 328 (3.47), 292 (3.44) nm; IR (KBr) νmax 3419,
2966, 1700, 1602, 1499, 1451, 1375, 1275, 1207, 1178, 1118, 1074,
9